Acadia Pharmaceuticals
Acadia Pharmaceuticals
Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California.
History[edit | edit source]
Acadia Pharmaceuticals was founded in 1993. The company initially focused on drug discovery and development for neurological and related central nervous system disorders. Over the years, Acadia has developed a pipeline of product candidates, with a particular focus on treatments for Parkinson's disease psychosis and other neuropsychiatric conditions.
Products[edit | edit source]
Acadia Pharmaceuticals is best known for its drug Pimavanserin, marketed under the brand name Nuplazid. Nuplazid is approved for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is a selective serotonin inverse agonist and antagonist preferentially targeting 5-HT2A receptors.
Research and Development[edit | edit source]
Acadia Pharmaceuticals has a robust research and development program aimed at discovering and developing new treatments for central nervous system disorders. The company's pipeline includes investigational drugs for conditions such as schizophrenia, major depressive disorder, and dementia-related psychosis.
Collaborations and Partnerships[edit | edit source]
Acadia Pharmaceuticals has engaged in various collaborations and partnerships to advance its research and development efforts. These collaborations have included partnerships with academic institutions, research organizations, and other pharmaceutical companies.
Financial Performance[edit | edit source]
Acadia Pharmaceuticals is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ACAD. The company has experienced significant growth in recent years, driven by the commercial success of Nuplazid and its ongoing research and development activities.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
